Organic nitroso compounds
![eMolecules 88050-17-3 | Fmoc-L-trans-4-hydroxyproline | Chem-Impex353.374 | C20H19NO5 | 99.000 | O[C@@H]1C[C@H](N(C1)C(=O)OCC1c2ccccc2-c2ccccc12)C(O)=O | 25g | 112443348](https://assets.fishersci.com/TFS-Assets/CCG/product-images/default.jpg-250.jpg)
eMolecules 88050-17-3 | Fmoc-L-trans-4-hydroxyproline | Chem-Impex353.374 | C20H19NO5 | 99.000 | O[C@@H]1C[C@H](N(C1)C(=O)OCC1c2ccccc2-c2ccccc12)C(O)=O | 25g | 112443348
Fmoc-L-trans-4-hydroxyproline | Chem-Impex | 88050-17-3353.374 | C20H19NO5 | 99.000 | O[C@@H]1C[C@H](N(C1)C(=O)OCC1c2ccccc2-c2ccccc12)C(O)=O | 25g | 112443348
Medchemexpress LLC N-Nitrosomorpholine | 59-89-2 | 100.0% | 1 ML
N-Nitrosomorpholine is a photosensitive nitrosamine that is carcinogenic and can be used to construct animal cancer models. It is for research use only and not sold to patients. High doses of N-Nitrosomorpholine can cause significant cytoplasmic and nuclear changes in livers, leading to toxic damage, single-cell necrosis, loss of glycogen, and induction of giant cell production, bile duct proliferation, and fibrosis. Cirrhosis becomes obvious by the 4th week of treatment, worsening by weeks 15-20, and leading to metastatic liver cancer and death in animals by weeks 30-40.
- Photosensitive nitrosamine
- Carcinogenic agent
- Used for animal cancer model construction
- For research use only
- Induces liver toxicity and cellular changes
- Causes necrosis and fibrosis in liver tissue
- Can lead to metastatic liver cancer and mortality in animals
SPEX CERTIPREP LLC 3P N-Nitrosodiethylamine 1000 µg/mL Solution Methanol Cas 55-18-5
N-Nitrosodiethylamine 1000 µg/mL Solution Methanol Cas 55-18-5
Sigma Aldrich Fine Chemicals Biosciences N Nitrosodiethylamine NDEA
This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.
Medchemexpress LLC (R)-PR-924 | 98.5% | 618.72 | 10 MG
(R)-PR-924 is an isomer of PR-924 used as an experimental control. PR-924 is a selective tripeptide epoxyketone immunoproteasome subunit LMP-7 inhibitor that covalently modifies proteasomal N-terminal threonine active sites. It inhibits growth and triggers apoptosis in multiple myeloma cells, demonstrating antitumor activities.
- Used as an experimental control
- Inhibits growth and triggers apoptosis in multiple myeloma cells
- Covalently modifies proteasomal N-terminal threonine active sites
- Acts as a selective tripeptide epoxyketone immunoproteasome subunit LMP-7 inhibitor
- Demonstrates antitumor activities
Selleck Chemical LLC N-Nitrosodiethylamine-E0136-1G
N-Nitrosodiethylamine (N-Nitroso-diethylamine NDEA diethylnitrosamine DEN) is DNA reactive after bioactivation and produces tumors in many animal species N-Nitrosodiethylamine can be used to induce animal models of Lung Carcinoma
Sigma Aldrich Fine Chemicals Biosciences N-Nitrosodiethylamine liquid | 55-18-5 | MFCD00013890 | 25ML
N-Nitrosodiethylamine liquid | Mol Wt: 102.14 | 55-18-5 | MFCD00013890 | 25ML
Sigma Aldrich Fine Chemicals Biosciences N-Nitrosodiethylamine liquid | 55-18-5 | MFCD00013890 | 10ML
N-Nitrosodiethylamine liquid | Mol Wt: 102.14 | 55-18-5 | MFCD00013890 | 10ML
Medchemexpress LLC S-nitroso-N-acetyl-DL-penicillamine | 67776-06-1 | 98.8% | 5 MG
S-nitroso-N-acetyl-DL-penicillamine (SNAP) is a nitric oxide donor commonly used in biochemical research to provide controlled NO release for studies of vascular function, signaling pathways, and platelet aggregation. It is supplied as a high-purity research chemical for in vitro experiments.
- Releases nitric oxide under physiological conditions.
- Suitable for studies of vasodilation and platelet aggregation.
- High purity (98.8% by HPLC) as confirmed by COA.
- Defined molecular properties: 220.25 g/mol, formula C7H12N2O4S.
- Available in small research pack sizes for laboratory use.